nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—ankylosing spondylitis	0.277	0.352	CbGbCtD
Perphenazine—CYP2C19—Prednisone—ankylosing spondylitis	0.0675	0.0857	CbGbCtD
Perphenazine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0663	0.0842	CbGbCtD
Perphenazine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0539	0.0684	CbGbCtD
Perphenazine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0502	0.0637	CbGbCtD
Perphenazine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0421	0.0535	CbGbCtD
Perphenazine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0408	0.0518	CbGbCtD
Perphenazine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.035	0.0445	CbGbCtD
Perphenazine—CYP3A4—Betamethasone—ankylosing spondylitis	0.035	0.0444	CbGbCtD
Perphenazine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0345	0.0439	CbGbCtD
Perphenazine—CYP3A4—Prednisone—ankylosing spondylitis	0.0326	0.0414	CbGbCtD
Perphenazine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.032	0.0407	CbGbCtD
Perphenazine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0204	0.0259	CbGbCtD
Perphenazine—Lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.00386	0.0246	CcSEcCtD
Perphenazine—Hypotensive—Dexamethasone—ankylosing spondylitis	0.00358	0.0228	CcSEcCtD
Perphenazine—Hypotensive—Betamethasone—ankylosing spondylitis	0.00358	0.0228	CcSEcCtD
Perphenazine—Retinal disorder—Methotrexate—ankylosing spondylitis	0.00266	0.0169	CcSEcCtD
Perphenazine—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.0026	0.0165	CcSEcCtD
Perphenazine—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00233	0.0423	CbGpPWpGaD
Perphenazine—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00233	0.0423	CbGpPWpGaD
Perphenazine—Glaucoma—Prednisolone—ankylosing spondylitis	0.00208	0.0132	CcSEcCtD
Perphenazine—Throat sore—Triamcinolone—ankylosing spondylitis	0.002	0.0127	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.00198	0.0126	CcSEcCtD
Perphenazine—Mydriasis—Prednisolone—ankylosing spondylitis	0.00196	0.0125	CcSEcCtD
Perphenazine—Glaucoma—Triamcinolone—ankylosing spondylitis	0.00191	0.0122	CcSEcCtD
Perphenazine—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.00191	0.0121	CcSEcCtD
Perphenazine—Sudden death—Methotrexate—ankylosing spondylitis	0.00186	0.0118	CcSEcCtD
Perphenazine—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00178	0.0113	CcSEcCtD
Perphenazine—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.00177	0.0113	CcSEcCtD
Perphenazine—Glaucoma—Dexamethasone—ankylosing spondylitis	0.00173	0.011	CcSEcCtD
Perphenazine—Glaucoma—Betamethasone—ankylosing spondylitis	0.00173	0.011	CcSEcCtD
Perphenazine—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.00163	0.0104	CcSEcCtD
Perphenazine—Glycosuria—Dexamethasone—ankylosing spondylitis	0.00161	0.0103	CcSEcCtD
Perphenazine—Glycosuria—Betamethasone—ankylosing spondylitis	0.00161	0.0103	CcSEcCtD
Perphenazine—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.00158	0.0101	CcSEcCtD
Perphenazine—Glaucoma—Prednisone—ankylosing spondylitis	0.00151	0.00962	CcSEcCtD
Perphenazine—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00149	0.00946	CcSEcCtD
Perphenazine—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00149	0.00946	CcSEcCtD
Perphenazine—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.00142	0.00906	CcSEcCtD
Perphenazine—Glycosuria—Prednisone—ankylosing spondylitis	0.0014	0.00894	CcSEcCtD
Perphenazine—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00129	0.00824	CcSEcCtD
Perphenazine—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.00129	0.00822	CcSEcCtD
Perphenazine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.00129	0.00822	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00117	0.00747	CcSEcCtD
Perphenazine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00108	0.00688	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00108	0.00687	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00108	0.00686	CcSEcCtD
Perphenazine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00102	0.00648	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—ankylosing spondylitis	0.001	0.0064	CcSEcCtD
Perphenazine—Muscular weakness—Prednisolone—ankylosing spondylitis	0.001	0.00638	CcSEcCtD
Perphenazine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000993	0.00632	CcSEcCtD
Perphenazine—Hyperkinesia—Prednisone—ankylosing spondylitis	0.000992	0.00631	CcSEcCtD
Perphenazine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000991	0.00631	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000979	0.00624	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000979	0.00624	CcSEcCtD
Perphenazine—Lethargy—Dexamethasone—ankylosing spondylitis	0.000967	0.00616	CcSEcCtD
Perphenazine—Lethargy—Betamethasone—ankylosing spondylitis	0.000967	0.00616	CcSEcCtD
Perphenazine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.000925	0.00589	CcSEcCtD
Perphenazine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.000925	0.00589	CcSEcCtD
Perphenazine—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.000921	0.00587	CcSEcCtD
Perphenazine—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.000919	0.00585	CcSEcCtD
Perphenazine—Asthma—Triamcinolone—ankylosing spondylitis	0.000903	0.00575	CcSEcCtD
Perphenazine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000901	0.00574	CcSEcCtD
Perphenazine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000901	0.00574	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—ankylosing spondylitis	0.000859	0.00547	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00085	0.00541	CcSEcCtD
Perphenazine—Lethargy—Prednisone—ankylosing spondylitis	0.000842	0.00536	CcSEcCtD
Perphenazine—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000836	0.00532	CcSEcCtD
Perphenazine—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000836	0.00532	CcSEcCtD
Perphenazine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.000806	0.00513	CcSEcCtD
Perphenazine—Bradycardia—Prednisolone—ankylosing spondylitis	0.0008	0.00509	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000785	0.005	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—ankylosing spondylitis	0.000785	0.005	CcSEcCtD
Perphenazine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000785	0.005	CcSEcCtD
Perphenazine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000739	0.00471	CcSEcCtD
Perphenazine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000739	0.00471	CcSEcCtD
Perphenazine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000736	0.00468	CcSEcCtD
Perphenazine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000734	0.00467	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000731	0.00466	CcSEcCtD
Perphenazine—Muscular weakness—Prednisone—ankylosing spondylitis	0.000728	0.00464	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000713	0.00454	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—ankylosing spondylitis	0.000704	0.00448	CcSEcCtD
Perphenazine—Erythema—Prednisolone—ankylosing spondylitis	0.000684	0.00436	CcSEcCtD
Perphenazine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000667	0.00425	CcSEcCtD
Perphenazine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000667	0.00425	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—ankylosing spondylitis	0.000649	0.00413	CcSEcCtD
Perphenazine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000645	0.0041	CcSEcCtD
Perphenazine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000643	0.0041	CcSEcCtD
Perphenazine—Erythema—Triamcinolone—ankylosing spondylitis	0.000629	0.00401	CcSEcCtD
Perphenazine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000628	0.004	CcSEcCtD
Perphenazine—Angioedema—Prednisolone—ankylosing spondylitis	0.000625	0.00398	CcSEcCtD
Perphenazine—Syncope—Prednisolone—ankylosing spondylitis	0.000613	0.00391	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000601	0.00383	CcSEcCtD
Perphenazine—Asthma—Methotrexate—ankylosing spondylitis	0.000596	0.0038	CcSEcCtD
Perphenazine—Convulsion—Prednisolone—ankylosing spondylitis	0.000593	0.00377	CcSEcCtD
Perphenazine—Hypertension—Prednisolone—ankylosing spondylitis	0.00059	0.00376	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00059	0.00376	CcSEcCtD
Perphenazine—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000586	0.0106	CbGpPWpGaD
Perphenazine—Bradycardia—Prednisone—ankylosing spondylitis	0.000581	0.0037	CcSEcCtD
Perphenazine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000575	0.00366	CcSEcCtD
Perphenazine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000573	0.00365	CcSEcCtD
Perphenazine—Erythema—Dexamethasone—ankylosing spondylitis	0.000571	0.00363	CcSEcCtD
Perphenazine—Erythema—Betamethasone—ankylosing spondylitis	0.000571	0.00363	CcSEcCtD
Perphenazine—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000567	0.0103	CbGpPWpGaD
Perphenazine—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000567	0.0103	CbGpPWpGaD
Perphenazine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000566	0.00361	CcSEcCtD
Perphenazine—Syncope—Triamcinolone—ankylosing spondylitis	0.000564	0.00359	CcSEcCtD
Perphenazine—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.000564	0.0102	CbGpPWpGaD
Perphenazine—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.000564	0.0102	CbGpPWpGaD
Perphenazine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000563	0.00358	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000558	0.00355	CcSEcCtD
Perphenazine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000553	0.00352	CcSEcCtD
Perphenazine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000552	0.00351	CcSEcCtD
Perphenazine—Shock—Prednisolone—ankylosing spondylitis	0.000549	0.0035	CcSEcCtD
Perphenazine—Cough—Triamcinolone—ankylosing spondylitis	0.000549	0.0035	CcSEcCtD
Perphenazine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000545	0.00347	CcSEcCtD
Perphenazine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000545	0.00347	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000544	0.00347	CcSEcCtD
Perphenazine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000544	0.00346	CcSEcCtD
Perphenazine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000543	0.00346	CcSEcCtD
Perphenazine—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000542	0.00983	CbGpPWpGaD
Perphenazine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000542	0.00345	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000531	0.00338	CcSEcCtD
Perphenazine—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000524	0.00951	CbGpPWpGaD
Perphenazine—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000524	0.00951	CbGpPWpGaD
Perphenazine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000524	0.00334	CcSEcCtD
Perphenazine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000521	0.00332	CcSEcCtD
Perphenazine—Angioedema—Betamethasone—ankylosing spondylitis	0.000521	0.00332	CcSEcCtD
Perphenazine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000516	0.00329	CcSEcCtD
Perphenazine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000513	0.00327	CcSEcCtD
Perphenazine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000512	0.00326	CcSEcCtD
Perphenazine—Syncope—Dexamethasone—ankylosing spondylitis	0.000512	0.00326	CcSEcCtD
Perphenazine—Syncope—Betamethasone—ankylosing spondylitis	0.000512	0.00326	CcSEcCtD
Perphenazine—Infection—Triamcinolone—ankylosing spondylitis	0.00051	0.00325	CcSEcCtD
Perphenazine—Infection—Methylprednisolone—ankylosing spondylitis	0.000509	0.00324	CcSEcCtD
Perphenazine—Shock—Triamcinolone—ankylosing spondylitis	0.000505	0.00322	CcSEcCtD
Perphenazine—Insomnia—Prednisolone—ankylosing spondylitis	0.000505	0.00322	CcSEcCtD
Perphenazine—Shock—Methylprednisolone—ankylosing spondylitis	0.000504	0.00321	CcSEcCtD
Perphenazine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000502	0.00319	CcSEcCtD
Perphenazine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000502	0.00319	CcSEcCtD
Perphenazine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000501	0.00319	CcSEcCtD
Perphenazine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0005	0.00318	CcSEcCtD
Perphenazine—Erythema—Prednisone—ankylosing spondylitis	0.000497	0.00317	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000496	0.00316	CcSEcCtD
Perphenazine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000494	0.00315	CcSEcCtD
Perphenazine—Convulsion—Betamethasone—ankylosing spondylitis	0.000494	0.00315	CcSEcCtD
Perphenazine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000493	0.00314	CcSEcCtD
Perphenazine—Hypertension—Betamethasone—ankylosing spondylitis	0.000493	0.00314	CcSEcCtD
Perphenazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000479	0.00305	CcSEcCtD
Perphenazine—Pain—Prednisolone—ankylosing spondylitis	0.000477	0.00304	CcSEcCtD
Perphenazine—HTR6—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000477	0.00865	CbGpPWpGaD
Perphenazine—HTR7—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000477	0.00864	CbGpPWpGaD
Perphenazine—Vision blurred—Prednisone—ankylosing spondylitis	0.000468	0.00298	CcSEcCtD
Perphenazine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000466	0.00297	CcSEcCtD
Perphenazine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000466	0.00297	CcSEcCtD
Perphenazine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000464	0.00296	CcSEcCtD
Perphenazine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000463	0.00295	CcSEcCtD
Perphenazine—Infection—Betamethasone—ankylosing spondylitis	0.000463	0.00295	CcSEcCtD
Perphenazine—Infection—Dexamethasone—ankylosing spondylitis	0.000463	0.00295	CcSEcCtD
Perphenazine—Shock—Betamethasone—ankylosing spondylitis	0.000458	0.00292	CcSEcCtD
Perphenazine—Shock—Dexamethasone—ankylosing spondylitis	0.000458	0.00292	CcSEcCtD
Perphenazine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000458	0.00291	CcSEcCtD
Perphenazine—Agitation—Prednisone—ankylosing spondylitis	0.000457	0.00291	CcSEcCtD
Perphenazine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000455	0.00289	CcSEcCtD
Perphenazine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000455	0.00289	CcSEcCtD
Perphenazine—Angioedema—Prednisone—ankylosing spondylitis	0.000454	0.00289	CcSEcCtD
Perphenazine—Syncope—Prednisone—ankylosing spondylitis	0.000446	0.00284	CcSEcCtD
Perphenazine—Anorexia—Betamethasone—ankylosing spondylitis	0.000444	0.00283	CcSEcCtD
Perphenazine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000444	0.00283	CcSEcCtD
Perphenazine—Urticaria—Prednisolone—ankylosing spondylitis	0.000443	0.00282	CcSEcCtD
Perphenazine—Pain—Triamcinolone—ankylosing spondylitis	0.000439	0.0028	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000437	0.00278	CcSEcCtD
Perphenazine—Hypotension—Betamethasone—ankylosing spondylitis	0.000435	0.00277	CcSEcCtD
Perphenazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000435	0.00277	CcSEcCtD
Perphenazine—Convulsion—Prednisone—ankylosing spondylitis	0.000431	0.00274	CcSEcCtD
Perphenazine—Hypertension—Prednisone—ankylosing spondylitis	0.000429	0.00273	CcSEcCtD
Perphenazine—Insomnia—Betamethasone—ankylosing spondylitis	0.000421	0.00268	CcSEcCtD
Perphenazine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000421	0.00268	CcSEcCtD
Perphenazine—Erythema—Methotrexate—ankylosing spondylitis	0.000415	0.00265	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000411	0.00262	CcSEcCtD
Perphenazine—DRD1—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000411	0.00745	CbGpPWpGaD
Perphenazine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000408	0.0026	CcSEcCtD
Perphenazine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000407	0.00259	CcSEcCtD
Perphenazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000406	0.00258	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000406	0.00258	CcSEcCtD
Perphenazine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000405	0.00258	CcSEcCtD
Perphenazine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000405	0.00258	CcSEcCtD
Perphenazine—Infection—Prednisone—ankylosing spondylitis	0.000403	0.00257	CcSEcCtD
Perphenazine—Shock—Prednisone—ankylosing spondylitis	0.000399	0.00254	CcSEcCtD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000398	0.00722	CbGpPWpGaD
Perphenazine—Pain—Betamethasone—ankylosing spondylitis	0.000398	0.00254	CcSEcCtD
Perphenazine—Pain—Dexamethasone—ankylosing spondylitis	0.000398	0.00254	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—ankylosing spondylitis	0.000396	0.00252	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000391	0.00249	CcSEcCtD
Perphenazine—Anorexia—Prednisone—ankylosing spondylitis	0.000387	0.00246	CcSEcCtD
Perphenazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000378	0.00241	CcSEcCtD
Perphenazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000377	0.0024	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000372	0.00237	CcSEcCtD
Perphenazine—Urticaria—Betamethasone—ankylosing spondylitis	0.00037	0.00236	CcSEcCtD
Perphenazine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00037	0.00236	CcSEcCtD
Perphenazine—Dizziness—Prednisolone—ankylosing spondylitis	0.000369	0.00235	CcSEcCtD
Perphenazine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000368	0.00234	CcSEcCtD
Perphenazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000368	0.00234	CcSEcCtD
Perphenazine—Insomnia—Prednisone—ankylosing spondylitis	0.000367	0.00234	CcSEcCtD
Perphenazine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000363	0.00231	CcSEcCtD
Perphenazine—Cough—Methotrexate—ankylosing spondylitis	0.000362	0.00231	CcSEcCtD
Perphenazine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000362	0.00231	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—ankylosing spondylitis	0.00036	0.00229	CcSEcCtD
Perphenazine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000353	0.00225	CcSEcCtD
Perphenazine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000351	0.00636	CbGpPWpGaD
Perphenazine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00035	0.00223	CcSEcCtD
Perphenazine—Headache—Prednisolone—ankylosing spondylitis	0.00035	0.00223	CcSEcCtD
Perphenazine—Constipation—Prednisone—ankylosing spondylitis	0.000347	0.00221	CcSEcCtD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000344	0.00624	CbGpPWpGaD
Perphenazine—Confusional state—Methotrexate—ankylosing spondylitis	0.000342	0.00218	CcSEcCtD
Perphenazine—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00034	0.00617	CbGpPWpGaD
Perphenazine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000339	0.00216	CcSEcCtD
Perphenazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000339	0.00615	CbGpPWpGaD
Perphenazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000339	0.00615	CbGpPWpGaD
Perphenazine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000339	0.00216	CcSEcCtD
Perphenazine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000339	0.00216	CcSEcCtD
Perphenazine—Infection—Methotrexate—ankylosing spondylitis	0.000337	0.00214	CcSEcCtD
Perphenazine—Pruritus—Betamethasone—ankylosing spondylitis	0.00033	0.0021	CcSEcCtD
Perphenazine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00033	0.0021	CcSEcCtD
Perphenazine—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000329	0.00597	CbGpPWpGaD
Perphenazine—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000329	0.00597	CbGpPWpGaD
Perphenazine—Anorexia—Methotrexate—ankylosing spondylitis	0.000323	0.00206	CcSEcCtD
Perphenazine—Urticaria—Prednisone—ankylosing spondylitis	0.000322	0.00205	CcSEcCtD
Perphenazine—Headache—Triamcinolone—ankylosing spondylitis	0.000322	0.00205	CcSEcCtD
Perphenazine—Headache—Methylprednisolone—ankylosing spondylitis	0.000321	0.00204	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000321	0.00204	CcSEcCtD
Perphenazine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000319	0.00203	CcSEcCtD
Perphenazine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000319	0.00203	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—ankylosing spondylitis	0.000317	0.00202	CcSEcCtD
Perphenazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00031	0.00562	CbGpPWpGaD
Perphenazine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000308	0.00196	CcSEcCtD
Perphenazine—Dizziness—Betamethasone—ankylosing spondylitis	0.000308	0.00196	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—ankylosing spondylitis	0.000307	0.00195	CcSEcCtD
Perphenazine—AOX1—Disease—ANTXR2—ankylosing spondylitis	0.000305	0.00552	CbGpPWpGaD
Perphenazine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000302	0.00192	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—ankylosing spondylitis	0.000301	0.00192	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000299	0.0019	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000295	0.00188	CcSEcCtD
Perphenazine—Headache—Betamethasone—ankylosing spondylitis	0.000292	0.00186	CcSEcCtD
Perphenazine—Headache—Dexamethasone—ankylosing spondylitis	0.000292	0.00186	CcSEcCtD
Perphenazine—Pain—Methotrexate—ankylosing spondylitis	0.00029	0.00185	CcSEcCtD
Perphenazine—Pruritus—Prednisone—ankylosing spondylitis	0.000287	0.00183	CcSEcCtD
Perphenazine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000278	0.00177	CcSEcCtD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000275	0.00498	CbGpPWpGaD
Perphenazine—Urticaria—Methotrexate—ankylosing spondylitis	0.000269	0.00172	CcSEcCtD
Perphenazine—Dizziness—Prednisone—ankylosing spondylitis	0.000268	0.00171	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000268	0.00171	CcSEcCtD
Perphenazine—HTR6—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000266	0.00481	CbGpPWpGaD
Perphenazine—HTR7—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000265	0.00481	CbGpPWpGaD
Perphenazine—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000257	0.00467	CbGpPWpGaD
Perphenazine—Headache—Prednisone—ankylosing spondylitis	0.000254	0.00162	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Perphenazine—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000249	0.00451	CbGpPWpGaD
Perphenazine—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000249	0.00451	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000247	0.00449	CbGpPWpGaD
Perphenazine—Pruritus—Methotrexate—ankylosing spondylitis	0.00024	0.00153	CcSEcCtD
Perphenazine—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000239	0.00434	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000239	0.00434	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000238	0.00431	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000232	0.00421	CbGpPWpGaD
Perphenazine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000232	0.00148	CcSEcCtD
Perphenazine—DRD1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000229	0.00414	CbGpPWpGaD
Perphenazine—HTR6—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000227	0.00412	CbGpPWpGaD
Perphenazine—HTR7—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000227	0.00412	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000224	0.00407	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000224	0.00407	CbGpPWpGaD
Perphenazine—Dizziness—Methotrexate—ankylosing spondylitis	0.000224	0.00143	CcSEcCtD
Perphenazine—Headache—Methotrexate—ankylosing spondylitis	0.000212	0.00135	CcSEcCtD
Perphenazine—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000205	0.00372	CbGpPWpGaD
Perphenazine—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000205	0.00371	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000198	0.0036	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000198	0.0036	CbGpPWpGaD
Perphenazine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000198	0.00359	CbGpPWpGaD
Perphenazine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000198	0.00359	CbGpPWpGaD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000198	0.00359	CbGpPWpGaD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000197	0.00357	CbGpPWpGaD
Perphenazine—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000197	0.00356	CbGpPWpGaD
Perphenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000196	0.00355	CbGpPWpGaD
Perphenazine—HTR2C—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000196	0.00355	CbGpPWpGaD
Perphenazine—AOX1—Disease—B3GNT2—ankylosing spondylitis	0.00018	0.00326	CbGpPWpGaD
Perphenazine—HTR6—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000173	0.00314	CbGpPWpGaD
Perphenazine—HTR7—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000173	0.00314	CbGpPWpGaD
Perphenazine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000173	0.00313	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000171	0.0031	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00017	0.00308	CbGpPWpGaD
Perphenazine—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00017	0.00308	CbGpPWpGaD
Perphenazine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000169	0.00307	CbGpPWpGaD
Perphenazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000168	0.00305	CbGpPWpGaD
Perphenazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000168	0.00304	CbGpPWpGaD
Perphenazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000161	0.00292	CbGpPWpGaD
Perphenazine—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000154	0.0028	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—B3GNT2—ankylosing spondylitis	0.00015	0.00273	CbGpPWpGaD
Perphenazine—DRD1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000149	0.0027	CbGpPWpGaD
Perphenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000148	0.00268	CbGpPWpGaD
Perphenazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000145	0.00264	CbGpPWpGaD
Perphenazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000145	0.00263	CbGpPWpGaD
Perphenazine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.000145	0.00263	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.000141	0.00255	CbGpPWpGaD
Perphenazine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.00014	0.00254	CbGpPWpGaD
Perphenazine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.00014	0.00254	CbGpPWpGaD
Perphenazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00014	0.00254	CbGpPWpGaD
Perphenazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00014	0.00253	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000136	0.00247	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000136	0.00247	CbGpPWpGaD
Perphenazine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000133	0.00242	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000133	0.00242	CbGpPWpGaD
Perphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000132	0.0024	CbGpPWpGaD
Perphenazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000129	0.00234	CbGpPWpGaD
Perphenazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000129	0.00234	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000129	0.00234	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000129	0.00234	CbGpPWpGaD
Perphenazine—HTR1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000128	0.00232	CbGpPWpGaD
Perphenazine—HTR2C—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000128	0.00231	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000127	0.0023	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000123	0.00223	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000123	0.00223	CbGpPWpGaD
Perphenazine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000121	0.0022	CbGpPWpGaD
Perphenazine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00012	0.00217	CbGpPWpGaD
Perphenazine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00012	0.00217	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000117	0.00213	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000117	0.00213	CbGpPWpGaD
Perphenazine—DRD2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000113	0.00204	CbGpPWpGaD
Perphenazine—HTR2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000111	0.00201	CbGpPWpGaD
Perphenazine—HRH1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000111	0.002	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000107	0.00194	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000103	0.00187	CbGpPWpGaD
Perphenazine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000103	0.00187	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—B3GNT2—ankylosing spondylitis	0.000102	0.00184	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000101	0.00183	CbGpPWpGaD
Perphenazine—CALM3—Disease—ANTXR2—ankylosing spondylitis	9.85e-05	0.00179	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.79e-05	0.00177	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.78e-05	0.00177	CbGpPWpGaD
Perphenazine—CALM2—Disease—ANTXR2—ankylosing spondylitis	9.53e-05	0.00173	CbGpPWpGaD
Perphenazine—CALM1—Disease—ANTXR2—ankylosing spondylitis	9.53e-05	0.00173	CbGpPWpGaD
Perphenazine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	9.26e-05	0.00168	CbGpPWpGaD
Perphenazine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	8.95e-05	0.00162	CbGpPWpGaD
Perphenazine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	8.95e-05	0.00162	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.89e-05	0.00161	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.88e-05	0.00161	CbGpPWpGaD
Perphenazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	8.63e-05	0.00156	CbGpPWpGaD
Perphenazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	8.63e-05	0.00156	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1R2—ankylosing spondylitis	8.53e-05	0.00155	CbGpPWpGaD
Perphenazine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	8.52e-05	0.00155	CbGpPWpGaD
Perphenazine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	8.52e-05	0.00155	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.43e-05	0.00153	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1R2—ankylosing spondylitis	8.25e-05	0.0015	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1R2—ankylosing spondylitis	8.25e-05	0.0015	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ERAP1—ankylosing spondylitis	8.08e-05	0.00147	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	7.97e-05	0.00145	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ERAP1—ankylosing spondylitis	7.82e-05	0.00142	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ERAP1—ankylosing spondylitis	7.82e-05	0.00142	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	7.71e-05	0.0014	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	7.71e-05	0.0014	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.65e-05	0.00139	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.65e-05	0.00139	CbGpPWpGaD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	7.49e-05	0.00136	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.4e-05	0.00134	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.4e-05	0.00134	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CARD9—ankylosing spondylitis	7.39e-05	0.00134	CbGpPWpGaD
Perphenazine—AOX1—Disease—HLA-A—ankylosing spondylitis	7.27e-05	0.00132	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.25e-05	0.00131	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.21e-05	0.00131	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CARD9—ankylosing spondylitis	7.15e-05	0.0013	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CARD9—ankylosing spondylitis	7.15e-05	0.0013	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.58e-05	0.00119	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.55e-05	0.00119	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	6.47e-05	0.00117	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.36e-05	0.00115	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—MMP3—ankylosing spondylitis	6.33e-05	0.00115	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—MMP3—ankylosing spondylitis	6.32e-05	0.00115	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.26e-05	0.00114	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.25e-05	0.00113	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	5.84e-05	0.00106	CbGpPWpGaD
Perphenazine—CALM3—Disease—B3GNT2—ankylosing spondylitis	5.8e-05	0.00105	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.78e-05	0.00105	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.7e-05	0.00103	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.69e-05	0.00103	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.67e-05	0.00103	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	5.65e-05	0.00102	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	5.65e-05	0.00102	CbGpPWpGaD
Perphenazine—CALM2—Disease—B3GNT2—ankylosing spondylitis	5.61e-05	0.00102	CbGpPWpGaD
Perphenazine—CALM1—Disease—B3GNT2—ankylosing spondylitis	5.61e-05	0.00102	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.45e-05	0.000988	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—B3GNT2—ankylosing spondylitis	5.33e-05	0.000966	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PTGER4—ankylosing spondylitis	5.25e-05	0.000952	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PTGER4—ankylosing spondylitis	5.25e-05	0.000951	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.17e-05	0.000938	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	4.99e-05	0.000906	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	4.86e-05	0.000881	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.76e-05	0.000863	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.72e-05	0.000856	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	4.71e-05	0.000855	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	4.7e-05	0.000853	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	4.7e-05	0.000853	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—MMP3—ankylosing spondylitis	4.69e-05	0.00085	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—MMP3—ankylosing spondylitis	4.66e-05	0.000845	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-C—ankylosing spondylitis	4.64e-05	0.000842	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.6e-05	0.000835	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.6e-05	0.000835	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.57e-05	0.000828	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.57e-05	0.000828	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	4.56e-05	0.000827	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	4.56e-05	0.000827	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.53e-05	0.000821	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.52e-05	0.00082	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-C—ankylosing spondylitis	4.49e-05	0.000814	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-C—ankylosing spondylitis	4.49e-05	0.000814	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.38e-05	0.000794	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.38e-05	0.000794	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	4.23e-05	0.000767	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.19e-05	0.00076	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	4.17e-05	0.000755	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—MMP3—ankylosing spondylitis	4.11e-05	0.000746	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.06e-05	0.000736	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.06e-05	0.000736	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—MMP3—ankylosing spondylitis	4.05e-05	0.000734	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—MMP3—ankylosing spondylitis	4.04e-05	0.000732	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1RN—ankylosing spondylitis	4.03e-05	0.000731	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	4.03e-05	0.000731	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	4.03e-05	0.000731	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	3.99e-05	0.000724	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1RN—ankylosing spondylitis	3.9e-05	0.000707	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1RN—ankylosing spondylitis	3.9e-05	0.000707	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.89e-05	0.000705	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTGER4—ankylosing spondylitis	3.87e-05	0.000701	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	3.86e-05	0.000701	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	3.86e-05	0.000701	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	3.77e-05	0.000684	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MMP3—ankylosing spondylitis	3.74e-05	0.000678	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MMP3—ankylosing spondylitis	3.74e-05	0.000677	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.68e-05	0.000668	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD79A—ankylosing spondylitis	3.54e-05	0.000642	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	3.47e-05	0.000629	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	3.44e-05	0.000624	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD79A—ankylosing spondylitis	3.43e-05	0.000621	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD79A—ankylosing spondylitis	3.43e-05	0.000621	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTGER4—ankylosing spondylitis	3.41e-05	0.000619	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	3.36e-05	0.000609	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.36e-05	0.000609	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.35e-05	0.000608	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.25e-05	0.000589	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	3.25e-05	0.000589	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MMP3—ankylosing spondylitis	3.22e-05	0.000584	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.06e-05	0.000554	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	2.94e-05	0.000533	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1A—ankylosing spondylitis	2.9e-05	0.000526	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD40LG—ankylosing spondylitis	2.89e-05	0.000523	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1A—ankylosing spondylitis	2.81e-05	0.000509	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1A—ankylosing spondylitis	2.81e-05	0.000509	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD40LG—ankylosing spondylitis	2.79e-05	0.000506	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD40LG—ankylosing spondylitis	2.79e-05	0.000506	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	2.79e-05	0.000505	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP3—ankylosing spondylitis	2.77e-05	0.000502	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP3—ankylosing spondylitis	2.75e-05	0.000499	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-B—ankylosing spondylitis	2.75e-05	0.000498	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.7e-05	0.000489	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.7e-05	0.000489	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-B—ankylosing spondylitis	2.66e-05	0.000482	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-B—ankylosing spondylitis	2.66e-05	0.000482	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-A—ankylosing spondylitis	2.54e-05	0.000461	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-A—ankylosing spondylitis	2.46e-05	0.000446	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-A—ankylosing spondylitis	2.46e-05	0.000446	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP3—ankylosing spondylitis	2.43e-05	0.000441	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CRP—ankylosing spondylitis	2.43e-05	0.00044	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP3—ankylosing spondylitis	2.39e-05	0.000434	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP3—ankylosing spondylitis	2.39e-05	0.000433	CbGpPWpGaD
Perphenazine—CALM3—Disease—HLA-A—ankylosing spondylitis	2.35e-05	0.000426	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CRP—ankylosing spondylitis	2.35e-05	0.000426	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CRP—ankylosing spondylitis	2.35e-05	0.000426	CbGpPWpGaD
Perphenazine—CALM3—Immune System—TLR4—ankylosing spondylitis	2.33e-05	0.000422	CbGpPWpGaD
Perphenazine—CALM2—Disease—HLA-A—ankylosing spondylitis	2.27e-05	0.000412	CbGpPWpGaD
Perphenazine—CALM1—Disease—HLA-A—ankylosing spondylitis	2.27e-05	0.000412	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.27e-05	0.000412	CbGpPWpGaD
Perphenazine—CALM2—Immune System—TLR4—ankylosing spondylitis	2.25e-05	0.000408	CbGpPWpGaD
Perphenazine—CALM1—Immune System—TLR4—ankylosing spondylitis	2.25e-05	0.000408	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP3—ankylosing spondylitis	2.18e-05	0.000394	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	1.98e-05	0.00036	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	1.92e-05	0.000348	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	1.92e-05	0.000348	CbGpPWpGaD
